Journal
BIOMARKERS
Volume 14, Issue 4, Pages 213-218Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/13547500902818246
Keywords
Bacillus Calmette-Guerin; urothelial bladder cancer; haplotype; polymorphism
Categories
Funding
- Department of Science and Technology New Delhi, India
- Department of Biotechnology, New Delhi India
Ask authors/readers for more resources
The association of interleukin-1 beta (IL-1 beta) -511C>T and IL-1 receptor antagonist (IL-1RN) VNTR, transforming growth factor-beta (TGF-B1) +28C>T and interferon-gamma (IFN-G)+874T>A polymorphisms with bladder cancer (CaB) susceptibility and risk of recurrence in Bacillus Calmette-Guerin (BCG)-treated patients was analyzed in 287 controls and 213 CaB patients (73 BCG treated). Increased risk was observed with the IL-1RN*2 allele (odds ratio (OR) 5.01) and the IFN-G +874 A allele (OR 1.78). TGF-BTT and IFN-G +874 A carriers were associated with reduced (hazard ratio (HR) 0.37) and enhanced (HR 2.24) risk of recurrence after BCG immunotherapy, respectively. The study suggests that cytokine gene variants may modulate CaB susceptibility and risk of recurrence after BCG immunotherapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available